These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26033719)

  • 1. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.
    Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine Antagonizes
    Howe MD; Kordus SL; Cole MS; Bauman AA; Aldrich CC; Baughn AD; Minato Y
    Front Cell Infect Microbiol; 2018; 8():399. PubMed ID: 30483484
    [No Abstract]   [Full Text] [Related]  

  • 3. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
    Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
    Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
    Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
    Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the promoter region of methionine transporter gene
    Zhang Y; Wang S; Chen X; Cui P; Chen J; Zhang W
    mBio; 2024 Feb; 15(2):e0207323. PubMed ID: 38179948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis.
    Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY
    Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
    Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P
    Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of
    Yang SS; Hu YB; Wang XD; Gao YR; Li K; Zhang XE; Chen SY; Zhang TY; Gu J; Deng JY
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The T120P or M172V mutation on
    Xu JT; Yu JF; Cheng T; Feng A; Yang P; Gu J; Yu HJ; Deng JY
    Emerg Microbes Infect; 2024 Dec; 13(1):2374030. PubMed ID: 39023395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.
    Wang W; Li S; Ge Q; Guo H; Shang Y; Ren W; Wang Y; Xue Z; Lu J; Pang Y
    Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):48. PubMed ID: 36335391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.
    Li G; Zhang J; Jiang Y; Zhao LL; Liu H; Li M; Zhao X; Wan K
    J Glob Antimicrob Resist; 2020 Mar; 20():275-281. PubMed ID: 31425771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand.
    Dokladda K; Billamas P; Jaitrong S; Suwanakitti N; Phornsiricharoenphant W; Viratyosin W; Prammananan T
    World J Microbiol Biotechnol; 2023 Dec; 40(1):32. PubMed ID: 38057660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance.
    Feuerriegel S; Köser C; Trübe L; Archer J; Rüsch Gerdes S; Richter E; Niemann S
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4794-8. PubMed ID: 20805400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to
    Yu JF; Xu JT; Yang SS; Gao MN; Si HR; Xiong DY; Gu J; Wu ZL; Zhou J; Deng JY
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0146521. PubMed ID: 34780266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].
    Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS).
    Hegde PV; Howe MD; Zimmerman MD; Boshoff HIM; Sharma S; Remache B; Jia Z; Pan Y; Baughn AD; Dartois V; Aldrich CC
    Eur J Med Chem; 2022 Mar; 232():114201. PubMed ID: 35219151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.
    Hajian B; Scocchera E; Shoen C; Krucinska J; Viswanathan K; G-Dayanandan N; Erlandsen H; Estrada A; Mikušová K; Korduláková J; Cynamon M; Wright D
    Cell Chem Biol; 2019 Jun; 26(6):781-791.e6. PubMed ID: 30930162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.
    Zhang X; Liu L; Zhang Y; Dai G; Huang H; Jin Q
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1320-4. PubMed ID: 25421465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
    Zheng J; Rubin EJ; Bifani P; Mathys V; Lim V; Au M; Jang J; Nam J; Dick T; Walker JR; Pethe K; Camacho LR
    J Biol Chem; 2013 Aug; 288(32):23447-56. PubMed ID: 23779105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
    Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
    Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.